Vericel Corporation (VCEL) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
Vericel (VCEL) Q2 2026: Macy Drives 23% Growth as $200M Buyback Signals Confident Cash Trajectory
July 30, 2026
-
Vericel (VCEL) Q1 2026: Burn Care Jumps 90%, Macy Sales Force Drives Sustained Growth
May 07, 2026
-
Vericel (VCEL) Q4 2025: Macy Franchise Grows 23% as Expanded Sales Force and Arthro Adoption Accelerate Penetration
February 26, 2026
-
Vericel (VCEL) Q3 2025: Macy Revenue Jumps 25% as Arthro Drives Implant Surge
November 06, 2025
-
Vericel (VCEL) Q2 2025: Macy Arthro Drives 40% Growth in Key Segment, Salesforce Expansion Accelerates
July 31, 2025
-
Vericel (VCEL) Q1 2025: Macy-Arthro Surgeons Drive 30%+ Biopsy Growth, Setting Up Back-Half Acceleration
July 07, 2025